Trevi Therapeutics (TRVI) Amortizatization of Intangibles (2022 - 2026)

Trevi Therapeutics' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $431000.0 for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles rose 9.11% year-over-year to $431000.0 in Q1 2026; TTM through Mar 2026 was $1.7 million, a 21.22% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 19.82% from the prior year.
• Amortizatization of Intangibles declined to $431000.0 in Q1 2026 per TRVI's latest filing, from $562000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $671000.0 in Q1 2023 and bottomed at $196000.0 in Q3 2022.
• The 5-year median for Amortizatization of Intangibles is $383000.0 (2025), against an average of $421200.0.
• Across the five-year window, Amortizatization of Intangibles surged 140.82% in 2023 and plunged 46.75% in 2024, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $561000.0 in 2022, then sank by 37.43% to $351000.0 in 2023, then slipped by 15.38% to $297000.0 in 2024, then soared by 89.23% to $562000.0 in 2025, then dropped by 23.31% to $431000.0 in 2026.
• Per Business Quant, the three latest TRVI Amortizatization of Intangibles figures stand at $431000.0 (Q1 2026), $562000.0 (Q4 2025), and $298000.0 (Q3 2025).